Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic Acid Receptor Alpha (RAR-α) is a nuclear hormone receptor and ligand-activated transcription factor encoded by the RARA gene. It plays a crucial role in regulating gene expression involved in cell differentiation, growth, hematopoiesis, spermatogenesis, and skeletal development. RAR-α heterodimerizes with RXR and binds to RAREs on DNA, modulating transcription in response to retinoid ligands. Aberrant RARA function, particularly through chromosomal translocations in acute promyelocytic leukemia, can disrupt normal cellular processes.
Ligand-dependent transcriptional activation or repression; heterodimerization with RXR; recruitment of coactivators or corepressors.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic Acid Receptor Alpha (RAR-α).